Patent Assignment
Reel/Frame 069379/0978
Change of Name
Recorded: 2024-11-18
Pages: 4
Assignor
OCUPHIRE PHARMA, INC.
Executed: 2024-10-22
Assignee
OPUS GENETICS, INC.
37000 GRAND RIVER AVE., SUITE 120, FARMINGTON HILLS, MICHIGAN, 48335
Covered Properties
(2)
Phentolamine Mesylate and Therapeutic Uses Thereof
Application:
18/587,397 →
Publication:
US 2025/0162995
Methods and Compositions for Treating Mydriasis, Glaucoma, and Other Ocular Conditions
Application:
18/556,599 →
Publication:
US 2024/0216334
Related Assignments
(5)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jun 7, 2024
From: ONICIU, DANIELA CARMEN
To: OCUPHIRE PHARMA, INC.
Reel/Frame 067652/0515 →
Assignment of Assignor's Interest
Jun 7, 2024
From: ESPINOSA FERRER, ROSA MARIA
To: SOLID TECHNOLOGIES SL
Reel/Frame 067652/0905 →
Assignment of Assignor's Interest
Jun 7, 2024
From: SOLID TECHNOLOGIES SL
To: OCUPHIRE PHARMA, INC.
Reel/Frame 067653/0018 →
Assignment of Assignor's Interest
Aug 8, 2024
From: PEPOSE, JAY STUART; LAZAR, ELIOT STUART; SOOCH, MINA; MEYER, ALAN R.
To: OCUPHIRE PHARMA, INC.
Reel/Frame 068226/0196 →
Security Interest
Apr 21, 2026
From: OPUS GENETICS, INC.
To: OPCM SA LLC, AS PURCHASER AGENT FOR THE SECURED PARTIES
Reel/Frame 075478/0138 →